Pharmablue

Pharmablue company information, Employees & Contact Information

Explore related pages

Related company profiles:

PharmaBlue is a partner "Exploitant" of innovative Pharma Companies for the marketing in France of their medicinal products which have been granted an Early Access Authorization (EAP) or a Marketing Authorization (MA). Our mission: PharmaBlue aims to contribute to a world where patients with unmet medical needs have better access to a variety of safe, effective healthcare products, and innovative treatments. PharmaBlue belongs to PharmaLex, which is a leading provider of specialized services for the pharmaceutical, biotech and MedTech industries. We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities.

Company Details

Employees
35
Founded
-
Address
16, Place De L'iris, Tour Cb 21,la Défense,france
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Courbevoie, Île-de-France
Looking for a particular Pharmablue employee's phone or email?

Pharmablue Questions

News

JNJ vs. MRK: Which Blue-Chip Pharma Stock Should Be in Your Portfolio? - Yahoo Finance

JNJ vs. MRK: Which Blue-Chip Pharma Stock Should Be in Your Portfolio? Yahoo Finance

Sun Pharma Announces FDA Approval of Next Generation BLU-U® Blue Light Photodynamic Therapy Illuminator for Actinic Keratosis - PR Newswire

Sun Pharma Announces FDA Approval of Next Generation BLU-U® Blue Light Photodynamic Therapy Illuminator for Actinic Keratosis PR Newswire

Alabama’s new pharmacy law takes effect today: What it means for your prescription costs - AL.com

Alabama’s new pharmacy law takes effect today: What it means for your prescription costs AL.com

Ionis Pharma Hits Four-Year High On A 'Home Run' In Triglycerides Treatment - Investor's Business Daily

Ionis Pharma Hits Four-Year High On A 'Home Run' In Triglycerides Treatment Investor's Business Daily

AstraZeneca: A Big Pharma Blue Chip To Buy Now (NASDAQ:AZN) - Seeking Alpha

AstraZeneca: A Big Pharma Blue Chip To Buy Now (NASDAQ:AZN) Seeking Alpha

Blue Owl Leads Around $4 Billion Debt Deal for PCI Pharma - Bloomberg

Blue Owl Leads Around $4 Billion Debt Deal for PCI Pharma Bloomberg

Blue Star, Natco Pharma Among Under-The-Radar Stocks With Upside Potential: SEBI RA Mayank Singh Chandel - Stocktwits

Blue Star, Natco Pharma Among Under-The-Radar Stocks With Upside Potential: SEBI RA Mayank Singh Chandel Stocktwits

Blue Cell Therapeutics appoints highly experienced pharma and biotech executive Olav Hellebø as Chairman of the Board of Directors - Yahoo Finance

Blue Cell Therapeutics appoints highly experienced pharma and biotech executive Olav Hellebø as Chairman of the Board of Directors Yahoo Finance

Sun Pharma rises after USFDA approves next-gen Blue Light PDT device for actinic keratosis - Business Standard

Sun Pharma rises after USFDA approves next-gen Blue Light PDT device for actinic keratosis Business Standard

Blue Owl Capital supports $4bn acquisition of PCI Pharma Services - Private Equity Insights

Blue Owl Capital supports $4bn acquisition of PCI Pharma Services Private Equity Insights

Macquarie initiates outperform rating on 4 Indian pharma stocks, sees 19-35% upside. Here's why - Mint

Macquarie initiates outperform rating on 4 Indian pharma stocks, sees 19-35% upside. Here's why Mint

AIM Market Roundup: Celadon Pharma, Blue Star Capital, Synergia - The Armchair Trader

AIM Market Roundup: Celadon Pharma, Blue Star Capital, Synergia The Armchair Trader

Blue Owl backs $4bn PCI Pharma deal - Private Equity Wire

Blue Owl backs $4bn PCI Pharma deal Private Equity Wire

Trade Spotlight: How should you trade Sun Pharma, Blue Star, Hero MotoCorp, Britannia, Acutaas Chemicals,... - Moneycontrol

Trade Spotlight: How should you trade Sun Pharma, Blue Star, Hero MotoCorp, Britannia, Acutaas Chemicals,... Moneycontrol

Blue Shield of California Unveils First-of-its-Kind Model to Transform Prescription Drug Care; Save up to $500 Million on Medications Annually - Blue Shield of California | News Center

Blue Shield of California Unveils First-of-its-Kind Model to Transform Prescription Drug Care; Save up to $500 Million on Medications Annually Blue Shield of California | News Center

Will Blue Shield’s New Pharma Model Disrupt the PBM Market? - American Hospital Association

Will Blue Shield’s New Pharma Model Disrupt the PBM Market? American Hospital Association

BLUE Software - Brand Lifecycle Management Platform for the Pharmaceutical Industry - Pharmaceutical Technology

BLUE Software - Brand Lifecycle Management Platform for the Pharmaceutical Industry Pharmaceutical Technology

Crinetics drug to challenge pharma ‘Goliaths’; FDA, ARPA move to speed gene therapies - BioPharma Dive

Crinetics drug to challenge pharma ‘Goliaths’; FDA, ARPA move to speed gene therapies BioPharma Dive

FDA’s new accelerated pathway may open pharma up to risks, as well as benefits - BioPharma Dive

FDA’s new accelerated pathway may open pharma up to risks, as well as benefits BioPharma Dive

Confessions of an Advertising Writer: How I Helped Pharma Sell Antidepressants - Mad In America

Confessions of an Advertising Writer: How I Helped Pharma Sell Antidepressants Mad In America

Q4 Results Today 2025: Aurobindo Pharma, Blue Dart Express, Firstcry Among 200+ Companies To Announce Earnings - NDTV Profit

Q4 Results Today 2025: Aurobindo Pharma, Blue Dart Express, Firstcry Among 200+ Companies To Announce Earnings NDTV Profit

Blue Shield of California bypasses PBMs to slash Humira prices by 90% - pharmaphorum

Blue Shield of California bypasses PBMs to slash Humira prices by 90% pharmaphorum

Seeking new social media horizons, EMA joins mass migration from X to Bluesky - Fierce Pharma

Seeking new social media horizons, EMA joins mass migration from X to Bluesky Fierce Pharma

MAHA may take aim at pharma DTC ads - BioPharma Dive

MAHA may take aim at pharma DTC ads BioPharma Dive

Bold moves, bolder vision: A CEO’s path for innovative pharma - McKinsey & Company

Bold moves, bolder vision: A CEO’s path for innovative pharma McKinsey & Company

Blue Shield California ditches CVS for Amazon and Mark Cuban’s drug company - CNN

Blue Shield California ditches CVS for Amazon and Mark Cuban’s drug company CNN

Use of horseshoe crabs’ blue blood puts pharma groups under scrutiny - Financial Times

Use of horseshoe crabs’ blue blood puts pharma groups under scrutiny Financial Times

Blue Shield of California drops CVS Caremark in pharmacy benefit overhaul - BioPharma Dive

Blue Shield of California drops CVS Caremark in pharmacy benefit overhaul BioPharma Dive

Untangling Sarepta’s gene therapy fallout and a growing trust deficit - Fierce Pharma

Untangling Sarepta’s gene therapy fallout and a growing trust deficit Fierce Pharma

In launching epinephrine nasal spray, ARS Pharma has a 'blue sky opportunity,' analyst says - Fierce Pharma

In launching epinephrine nasal spray, ARS Pharma has a 'blue sky opportunity,' analyst says Fierce Pharma

Amylyx drug comes up short; Sanofi names new CMO - BioPharma Dive

Amylyx drug comes up short; Sanofi names new CMO BioPharma Dive

Phathom Pharmaceuticals aims to 'kick some acid' with first Voquezna campaign - Fierce Pharma

Phathom Pharmaceuticals aims to 'kick some acid' with first Voquezna campaign Fierce Pharma

Tata Investment Corp, Strides Pharma, Blue Jet Healthcare: How to trade these buzzing 3 stocks - Business Today

Tata Investment Corp, Strides Pharma, Blue Jet Healthcare: How to trade these buzzing 3 stocks Business Today

Grow Pharma Expands Grow Access Project to Blue Light Card Holders - Business of Cannabis

Grow Pharma Expands Grow Access Project to Blue Light Card Holders Business of Cannabis

Trump Demands U.S. Drug Price Cuts, Sending Pharma Shares Slumping - Supply Chain Brain

Trump Demands U.S. Drug Price Cuts, Sending Pharma Shares Slumping Supply Chain Brain

AstraZeneca cuts US drug pricing deal; FDA declares Novo plant out of compliance - BioPharma Dive

AstraZeneca cuts US drug pricing deal; FDA declares Novo plant out of compliance BioPharma Dive

FDA official’s comments spark Aurinia sell-off; Halozyme buys a biotech - BioPharma Dive

FDA official’s comments spark Aurinia sell-off; Halozyme buys a biotech BioPharma Dive

7 Best Pharmaceutical Stocks to Buy for Income | Investing - US News Money

7 Best Pharmaceutical Stocks to Buy for Income | Investing US News Money

Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond - BioSpace

Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond BioSpace

Vertex secures Alyftrek coverage in England; Merck starts Phase 3 trials of HIV drug - BioPharma Dive

Vertex secures Alyftrek coverage in England; Merck starts Phase 3 trials of HIV drug BioPharma Dive

BridgeBio Pharma Secures up to $1.25 Billion of Capital - GlobeNewswire

BridgeBio Pharma Secures up to $1.25 Billion of Capital GlobeNewswire

With deal to buy 7 Recipharm plants, private equity firm Blue Wolf plans new CDMO - Fierce Pharma

With deal to buy 7 Recipharm plants, private equity firm Blue Wolf plans new CDMO Fierce Pharma

American Society for Meningitis Prevention paints the town purple and blue for World Meningitis Day - Fierce Pharma

American Society for Meningitis Prevention paints the town purple and blue for World Meningitis Day Fierce Pharma

BridgeBio strikes drug royalty deal for cash infusion - BioPharma Dive

BridgeBio strikes drug royalty deal for cash infusion BioPharma Dive

Eli Lilly pulls Twitter ads after blue check fallout: report - Fierce Pharma

Eli Lilly pulls Twitter ads after blue check fallout: report Fierce Pharma

Horseshoe crab blood is vital for testing intravenous drugs, but new synthetic alternatives could mean pharma won’t bleed this unique species dry - The Conversation

Horseshoe crab blood is vital for testing intravenous drugs, but new synthetic alternatives could mean pharma won’t bleed this unique species dry The Conversation

Madrigal buys into GLP-1 from CSPC; Apellis wins expanded drug approval - BioPharma Dive

Madrigal buys into GLP-1 from CSPC; Apellis wins expanded drug approval BioPharma Dive

Eli Lilly issues rare apology as fake Twitter Blue account proclaims free insulin for all - Fierce Pharma

Eli Lilly issues rare apology as fake Twitter Blue account proclaims free insulin for all Fierce Pharma

Pharma colors and marketing: Typically ‘awash in blue,’ newer brand updates adopt bold hues - Endpoints News

Pharma colors and marketing: Typically ‘awash in blue,’ newer brand updates adopt bold hues Endpoints News

Blue Water buys enlarged prostate drug Entadfi from Veru for up to $100M - Fierce Pharma

Blue Water buys enlarged prostate drug Entadfi from Veru for up to $100M Fierce Pharma

Technology and Transparency: How the Pharma Supply Chain Must Adapt - Supply Chain Brain

Technology and Transparency: How the Pharma Supply Chain Must Adapt Supply Chain Brain

Bain Capital eyes $10bn healthcare buyout with exclusive bid for PCI Pharma - Private Equity Insights

Bain Capital eyes $10bn healthcare buyout with exclusive bid for PCI Pharma Private Equity Insights

Replimune drug rejected by FDA; Omega raises $647M biotech fund - BioPharma Dive

Replimune drug rejected by FDA; Omega raises $647M biotech fund BioPharma Dive

Biotech Finally Has an IPO After Months-Long Freeze - BioSpace

Biotech Finally Has an IPO After Months-Long Freeze BioSpace

Common Side Effects review: Stunning new animated series tells the story of a cure-all mushroom - New Scientist

Common Side Effects review: Stunning new animated series tells the story of a cure-all mushroom New Scientist

Gillette India, Aurobindo Pharma, Blue Dart, Bajaj Healthcare Among 205 Companies To Announce Q4 Results Today - Goodreturns

Gillette India, Aurobindo Pharma, Blue Dart, Bajaj Healthcare Among 205 Companies To Announce Q4 Results Today Goodreturns

Chair of Pharma-Funded Blue Dogs Pushes for Drug Company Protections in New NAFTA - readsludge.com

Chair of Pharma-Funded Blue Dogs Pushes for Drug Company Protections in New NAFTA readsludge.com

‘Blue-hat’ charm: Sirio Pharma gains approval for three probiotics formulations - NutraIngredients.com

‘Blue-hat’ charm: Sirio Pharma gains approval for three probiotics formulations NutraIngredients.com

'Common Side Effects' Review: Fighting Big Pharma Has Never Been Such Fun - MovieWeb

'Common Side Effects' Review: Fighting Big Pharma Has Never Been Such Fun MovieWeb

BlueWhale Bio surfaces with $18M on mission to overhaul cell therapy production - Fierce Pharma

BlueWhale Bio surfaces with $18M on mission to overhaul cell therapy production Fierce Pharma

Techdow USA and CTTQ Pharma Announce Collaboration Agreement and Launch of Fosaprepitant for Injection - Business Wire

Techdow USA and CTTQ Pharma Announce Collaboration Agreement and Launch of Fosaprepitant for Injection Business Wire

9 Big Pharmaceutical Stocks Sporting Stellar Yields - Kiplinger

9 Big Pharmaceutical Stocks Sporting Stellar Yields Kiplinger

In silico techniques – a JPAG event - European Pharmaceutical Review

In silico techniques – a JPAG event European Pharmaceutical Review

Blue-blooded crabs at heart of pharma dispute on drug testing - Reuters

Blue-blooded crabs at heart of pharma dispute on drug testing Reuters

Bioniche Pharma and Synerx Launch Isosulfan Blue Injection 1% - PR Newswire

Bioniche Pharma and Synerx Launch Isosulfan Blue Injection 1% PR Newswire

Merck KGaA puts devices to work against diabetes in Blue Mesa digital program - Fierce Pharma

Merck KGaA puts devices to work against diabetes in Blue Mesa digital program Fierce Pharma

The Viagra effect: Sales of Lilly's ED drug Cialis slide after little blue pill goes generic - Fierce Pharma

The Viagra effect: Sales of Lilly's ED drug Cialis slide after little blue pill goes generic Fierce Pharma

OTC Viagra: Pfizer snags nod for nonprescription sales of the little blue pill for men in the U.K. - Fierce Pharma

OTC Viagra: Pfizer snags nod for nonprescription sales of the little blue pill for men in the U.K. Fierce Pharma

Investors left feeling blue as Cerulean admits defeat on cancer pipeline - Fierce Biotech

Investors left feeling blue as Cerulean admits defeat on cancer pipeline Fierce Biotech

Hikma set to join pharma blue-chips in UK market - Financial Times

Hikma set to join pharma blue-chips in UK market Financial Times

Top Pharmablue Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant